Articles

  • KSBNS 2024

Article

Original Article

Exp Neurobiol 2016; 25(1): 14-23

Published online February 29, 2016

https://doi.org/10.5607/en.2016.25.1.14

© The Korean Society for Brain and Neural Sciences

PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation

Insup Choi1,2, Joo Hong Woo2, Ilo Jou1,2,3 and Eun-hye Joe1,2,3,4,5*

1Neuroscience Graduate Program Department of Biomedical Sciences, 2Chronic Inflammatory Disease Research Center, 3Department of Pharmacology, 4Department of Brain Science, 5Brain Disease Research Center, Ajou University School of Medicine, Suwon 16499, Korea

Correspondence to: *To whom correspondence should be addressed.
TEL: 82-31-219-5062, FAX: 82-31-219-5069
e-mail: ehjoe@ajou.ac.kr

Received: November 12, 2015; Revised: January 27, 2016; Accepted: January 27, 2016

Abstract

PTEN-induced putative kinase 1 (PINK1) is a Parkinson's disease (PD) gene. We examined miRNAs regulated by PINK1 during brain development and neural stem cell (NSC) differentiation, and found that lvels of miRNAs related to tumors and inflammation were different between 1-day-old-wild type (WT) and PINK1-knockout (KO) mouse brains. Notably, levels of miR-326, miR-330 and miR-3099, which are related to astroglioma, increased during brain development and NSC differentiation, and were significantly reduced in the absence of PINK1. Interestingly, in the presence of ciliary neurotrophic factor (CNTF), which pushes differentiation of NSCs into astrocytes, miR-326, miR-330, and miR-3099 levels in KO NSCs were also lower than those in WT NSCs. Furthermore, mimics of all three miRNAs increased expression of the astrocytic marker glial fibrillary acidic protein (GFAP) during differentiation of KO NSCs, but inhibitors of these miRNAs decreased GFAP expression in WT NSCs. Moreover, these miRNAs increased the translational efficacy of GFAP through the 3'-UTR of GFAP mRNA. Taken together, these results suggest that PINK1 deficiency reduce expression levels of miR-326, miR-330 and miR-3099, which may regulate GFAP expression during NSC differentiation and brain development.

Keywords: PINK1, Parkinson’s disease, miR-326, miR-330, miR-3099